A rare cause of childhood renal cysts: Xp11.2 translocation renal cell carcinoma.
暂无分享,去创建一个
A. Polat | D. Avlan | Ç. Çıtak | Hakan Taşkınlar | A. Nayci
[1] T. Whelan. Guidelines on the management of renal cyst disease. , 2010, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.
[2] Ming Zhou,et al. Rapid Development of Metastatic Xp11 Translocation Renal Cell Carcinoma in a Girl Treated for Neuroblastoma , 2009, Journal of pediatric hematology/oncology.
[3] L. Cheng,et al. Renal cell carcinoma in children and young adults: analysis of clinicopathological, immunohistochemical and molecular characteristics with an emphasis on the spectrum of Xp11.2 translocation‐associated and unusual clear cell subtypes , 2008, Histopathology.
[4] D. Bägli,et al. Risk assessment of incidentally detected complex renal cysts in children: potential role for a modification of the Bosniak classification. , 2008, The Journal of urology.
[5] C. Kane,et al. Renal cell carcinoma in the pediatric population: Results from the California Cancer Registry , 2008, Pediatric blood & cancer.
[6] P. Argani,et al. Translocation renal cell carcinoma , 2008, Cancer.
[7] M. Ladanyi,et al. TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition. , 2007, Cancer research.
[8] P. Russo. Pediatric renal cell carcinoma: Single institution 25 year case series and initial experience with partial nephrectomy , 2006 .
[9] G. Israel,et al. An update of the Bosniak renal cyst classification system. , 2005, Urology.
[10] M. Ladanyi,et al. Translocation carcinomas of the kidney. , 2005, Clinics in laboratory medicine.
[11] H. Moch,et al. [Pediatric renal cell carcinoma]. , 2004, Der Pathologe.
[12] M. Ladanyi,et al. Aberrant Nuclear Immunoreactivity for TFE3 in Neoplasms With TFE3 Gene Fusions: A Sensitive and Specific Immunohistochemical Assay , 2003, The American journal of surgical pathology.
[13] A. Renshaw,et al. Renal cell carcinomas in children and young adults: increased incidence of papillary architecture and unique subtypes. , 1999, The American journal of surgical pathology.
[14] G. Reaman,et al. A phase II trial of human recombinant lnterleukin‐2 administered as a 4‐day continuous infusion for children with refractory neuroblastoma, non‐Hodgkin's lymphoma, sarcoma, renal cell carcinoma, and malignant melanoma. A childrens cancer group study , 1995, Cancer.
[15] Yifan Li,et al. Xp11.2 translocation renal cell carcinoma with multiple bone metastases: A case report. , 2016, Oncology letters.
[16] A. Marx,et al. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs , 2004 .